Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sequence Deletion | 1 | 2019 | 674 | 0.58 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 11 | 2020 | 8843 | 0.52 | Why? |
| Virus Replication | 4 | 2020 | 14331 | 0.24 | Why? |
| Student Health Services | 1 | 2021 | 69 | 0.21 | Why? |
| Antibodies, Viral | 16 | 2022 | 51949 | 0.20 | Why? |
| Ribonucleosides | 1 | 2020 | 95 | 0.20 | Why? |
| Saudi Arabia | 5 | 2019 | 4423 | 0.17 | Why? |
| Henipavirus | 1 | 2017 | 24 | 0.17 | Why? |
| 5' Untranslated Regions | 1 | 2019 | 375 | 0.16 | Why? |
| Disease Transmission, Infectious | 4 | 2021 | 9044 | 0.16 | Why? |
| SARS Virus | 9 | 2020 | 13021 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.15 | Why? |
| Henipavirus Infections | 1 | 2017 | 122 | 0.15 | Why? |
| Open Reading Frames | 2 | 2019 | 1898 | 0.13 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.12 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.12 | Why? |
| Nucleocapsid Proteins | 5 | 2020 | 3120 | 0.12 | Why? |
| Membrane Glycoproteins | 4 | 2009 | 2273 | 0.12 | Why? |
| Community Health Services | 1 | 2021 | 1000 | 0.11 | Why? |
| Antigens, Viral | 4 | 2021 | 6298 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Skilled Nursing Facilities | 1 | 2020 | 1098 | 0.11 | Why? |
| Washington | 3 | 2021 | 1722 | 0.11 | Why? |
| Asymptomatic Diseases | 2 | 2021 | 3444 | 0.11 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Viral Envelope Proteins | 5 | 2009 | 3539 | 0.10 | Why? |
| Camelus | 1 | 2018 | 1425 | 0.10 | Why? |
| Wisconsin | 2 | 2021 | 607 | 0.09 | Why? |
| Coronavirus Infections | 15 | 2020 | 253789 | 0.09 | Why? |
| RNA, Viral | 7 | 2021 | 32276 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.09 | Why? |
| Whole Genome Sequencing | 1 | 2019 | 3239 | 0.09 | Why? |
| Reverse Transcription | 2 | 2022 | 673 | 0.09 | Why? |
| Genotype | 1 | 2019 | 4697 | 0.08 | Why? |
| Antibodies, Monoclonal | 3 | 2021 | 8041 | 0.08 | Why? |
| Measles Vaccine | 2 | 2008 | 301 | 0.08 | Why? |
| Measles virus | 1 | 2008 | 194 | 0.08 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.07 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.07 | Why? |
| Animals | 11 | 2021 | 78931 | 0.07 | Why? |
| Severe Acute Respiratory Syndrome | 7 | 2009 | 12361 | 0.07 | Why? |
| Selection, Genetic | 1 | 2008 | 691 | 0.07 | Why? |
| Maternal-Fetal Exchange | 1 | 2006 | 209 | 0.07 | Why? |
| Cross Infection | 2 | 2019 | 8675 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.07 | Why? |
| Humans | 39 | 2022 | 930598 | 0.06 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.06 | Why? |
| Biological Evolution | 1 | 2008 | 641 | 0.06 | Why? |
| Immunoassay | 1 | 2019 | 4485 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 10 | 2021 | 37182 | 0.06 | Why? |
| Disease Outbreaks | 4 | 2021 | 27595 | 0.06 | Why? |
| Jordan | 2 | 2016 | 701 | 0.06 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.06 | Why? |
| Chiroptera | 1 | 2017 | 3530 | 0.06 | Why? |
| Iowa | 1 | 2021 | 111 | 0.06 | Why? |
| Viral Structural Proteins | 1 | 2005 | 491 | 0.06 | Why? |
| Oregon | 1 | 2021 | 224 | 0.05 | Why? |
| Contact Tracing | 2 | 2019 | 8448 | 0.05 | Why? |
| Fluoresceins | 1 | 2020 | 46 | 0.05 | Why? |
| Antibody Specificity | 1 | 2005 | 1328 | 0.05 | Why? |
| Louisiana | 1 | 2021 | 353 | 0.05 | Why? |
| Rhode Island | 1 | 2021 | 425 | 0.05 | Why? |
| Adult | 15 | 2022 | 244371 | 0.05 | Why? |
| Arizona | 1 | 2021 | 416 | 0.05 | Why? |
| Utah | 1 | 2020 | 425 | 0.05 | Why? |
| Half-Life | 1 | 2020 | 298 | 0.05 | Why? |
| Connecticut | 1 | 2021 | 547 | 0.05 | Why? |
| Hydroxylamines | 1 | 2020 | 182 | 0.05 | Why? |
| Mice | 4 | 2021 | 21357 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2020 | 501 | 0.05 | Why? |
| Cytidine | 1 | 2020 | 219 | 0.04 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 393 | 0.04 | Why? |
| Adenoviridae | 1 | 2003 | 1151 | 0.04 | Why? |
| Infection Control | 4 | 2020 | 23131 | 0.04 | Why? |
| Microspheres | 1 | 2019 | 261 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Random Allocation | 1 | 2020 | 773 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2022 | 13720 | 0.04 | Why? |
| Seroepidemiologic Studies | 3 | 2019 | 10017 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2020 | 399 | 0.04 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.04 | Why? |
| Fluorescence | 1 | 2019 | 475 | 0.04 | Why? |
| Aviation | 1 | 2017 | 77 | 0.04 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.04 | Why? |
| Female | 15 | 2022 | 380317 | 0.04 | Why? |
| Massachusetts | 1 | 2021 | 1279 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| United Arab Emirates | 1 | 2019 | 704 | 0.04 | Why? |
| Fluorescent Dyes | 1 | 2020 | 536 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Male | 14 | 2022 | 367725 | 0.04 | Why? |
| Universities | 2 | 2021 | 4374 | 0.04 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.04 | Why? |
| Fomites | 1 | 2021 | 709 | 0.04 | Why? |
| Genome, Viral | 3 | 2020 | 13157 | 0.04 | Why? |
| Sequence Homology | 1 | 2016 | 448 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus | 3 | 2019 | 18339 | 0.03 | Why? |
| Viral Vaccines | 2 | 2008 | 7560 | 0.03 | Why? |
| Cats | 1 | 2021 | 1890 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Middle Aged | 10 | 2022 | 270681 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Family Health | 1 | 2019 | 731 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.03 | Why? |
| Genes, Viral | 1 | 2019 | 1428 | 0.03 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.03 | Why? |
| Adolescent | 5 | 2022 | 86841 | 0.03 | Why? |
| Neutralization Tests | 4 | 2009 | 6698 | 0.03 | Why? |
| Immunity, Cellular | 1 | 2006 | 3614 | 0.03 | Why? |
| Macrophages | 1 | 2005 | 2784 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.03 | Why? |
| Epitope Mapping | 2 | 2009 | 1240 | 0.03 | Why? |
| Sequence Analysis, DNA | 2 | 2016 | 2830 | 0.03 | Why? |
| Monocytes | 1 | 2005 | 2978 | 0.03 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Young Adult | 5 | 2022 | 93724 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Prisons | 1 | 2021 | 980 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Base Sequence | 1 | 2019 | 3581 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2016 | 1638 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Amino Acid Sequence | 3 | 2009 | 6049 | 0.03 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Israel | 1 | 2018 | 2751 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Cytidine Deaminase | 1 | 2008 | 109 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Complementarity Determining Regions | 1 | 2008 | 147 | 0.02 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.02 | Why? |
| Molecular Sequence Data | 2 | 2004 | 3198 | 0.02 | Why? |
| Cluster Analysis | 1 | 2016 | 3001 | 0.02 | Why? |
| Animals, Genetically Modified | 1 | 2008 | 230 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.02 | Why? |
| Cross Reactions | 1 | 2019 | 4374 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Receptors, Virus | 1 | 2004 | 5659 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Viral Matrix Proteins | 2 | 2005 | 1243 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2020 | 10998 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Nursing Homes | 1 | 2022 | 4155 | 0.02 | Why? |
| Viral Proteins | 1 | 2003 | 7370 | 0.02 | Why? |
| Immune Sera | 1 | 2008 | 884 | 0.02 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.02 | Why? |
| Immunoglobulin Light Chains | 1 | 2004 | 62 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Gene Library | 1 | 2004 | 234 | 0.02 | Why? |
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 95 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2004 | 222 | 0.02 | Why? |
| Phagocytosis | 1 | 2005 | 409 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.02 | Why? |
| Endopeptidases | 1 | 2003 | 228 | 0.01 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.01 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.01 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.01 | Why? |
| Phylogeny | 2 | 2016 | 13341 | 0.01 | Why? |
| Microscopy, Electron | 1 | 2005 | 830 | 0.01 | Why? |
| Monkey Diseases | 1 | 2003 | 190 | 0.01 | Why? |
| Giant Cells | 1 | 2004 | 334 | 0.01 | Why? |
| Blotting, Western | 1 | 2003 | 863 | 0.01 | Why? |
| In Vitro Techniques | 1 | 2005 | 1027 | 0.01 | Why? |
| Sequence Homology, Amino Acid | 1 | 2004 | 945 | 0.01 | Why? |
| DNA, Complementary | 1 | 2003 | 568 | 0.01 | Why? |
| Genetic Vectors | 1 | 2008 | 1600 | 0.01 | Why? |
| Conserved Sequence | 1 | 2003 | 751 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Polyproteins | 1 | 2003 | 814 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2021 | 9659 | 0.01 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Travel | 1 | 2017 | 7220 | 0.01 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.01 | Why? |
| Sequence Alignment | 1 | 2004 | 2109 | 0.01 | Why? |
| Transcription, Genetic | 1 | 2003 | 1326 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Interferon-alpha | 1 | 2005 | 1442 | 0.01 | Why? |
| Health Personnel | 2 | 2019 | 29646 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Vaccines, Synthetic | 1 | 2008 | 3231 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Macaca mulatta | 1 | 2003 | 3716 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Vaccination | 2 | 2006 | 19050 | 0.01 | Why? |
| RNA, Messenger | 1 | 2003 | 5131 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2003 | 6670 | 0.00 | Why? |
| Pregnancy | 1 | 2006 | 23879 | 0.00 | Why? |